Literature DB >> 1984642

The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity.

L G Baum1, J C Paulson.   

Abstract

A survey of 10 human influenza A viruses of the N2 serotype, isolated between 1957 and 1987, has revealed a drift in neuraminidase linkage specificity. While the earliest N2 strains examined exhibit strict specificity for cleavage of the NeuAc alpha 2,3Gal sequence, N2 isolates from 1967 to 1968 also show limited activity towards the NeuAc alpha 2,6Gal linkage. In strains isolated in 1972 and later, the N2 neuraminidase has approximately equal activity towards both types of linkages. The NeuAc alpha 2,6Gal linkage cleaved by the later N2 neuraminidases is the preferred receptor determinant of human H2 and H3 hemagglutinins. Thus, the acquired neuraminidase specificity of the later isolates allows elution of bound virus from erythrocytes derivatized to contain the NeuAc alpha 2,6Gal linkage, while earlier isolates, which cleave only the NeuAc alpha 2,3Gal sequence, fail to elute from these erythrocytes. These results suggest that the observed drift in N2 neuraminidase specificity in the direction of the preferred H2 and H3 receptor determinant may facilitate release of progeny virus from host cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984642     DOI: 10.1016/0042-6822(91)90003-t

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  51 in total

1.  Binding affinity of GM3 lactone for influenza virus.

Authors:  T Sato; M Ishii; F Ohtake; K Nagata; T Terabayashi; Y Kawanishi; Y Okahata
Journal:  Glycoconj J       Date:  1999-03       Impact factor: 2.916

2.  Substrate specificity of avian influenza H5N1 neuraminidase.

Authors:  Naruthai Onsirisakul; Shin-Ichi Nakakita; Chompunuch Boonarkart; Alita Kongchanagul; Ornpreya Suptawiwat; Pilaipan Puthavathana; Krisada Chaichuen; Kanokwan Kittiniyom; Yasuo Suzuki; Prasert Auewarakul
Journal:  World J Virol       Date:  2014-11-12

3.  Sialic acid species as a determinant of the host range of influenza A viruses.

Authors:  Y Suzuki; T Ito; T Suzuki; R E Holland; T M Chambers; M Kiso; H Ishida; Y Kawaoka
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice.

Authors:  P C Reading; L S Morey; E C Crouch; E M Anders
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003.

Authors:  U B Aamir; Ulrich Wernery; N Ilyushina; R G Webster
Journal:  Virology       Date:  2006-12-08       Impact factor: 3.616

6.  Influenza virus neuraminidase contributes to secondary bacterial pneumonia.

Authors:  Ville T Peltola; K Gopal Murti; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2005-06-08       Impact factor: 5.226

7.  Adaptation of avian influenza A (H6N1) virus from avian to human receptor-binding preference.

Authors:  Fei Wang; Jianxun Qi; Yuhai Bi; Wei Zhang; Min Wang; Baorong Zhang; Ming Wang; Jinhua Liu; Jinghua Yan; Yi Shi; George F Gao
Journal:  EMBO J       Date:  2015-05-04       Impact factor: 11.598

Review 8.  Transmission of influenza A viruses.

Authors:  Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Virology       Date:  2015-03-24       Impact factor: 3.616

9.  Host Enzymes Heparanase and Cathepsin L Promote Herpes Simplex Virus 2 Release from Cells.

Authors:  James Hopkins; Tejabhiram Yadavalli; Alex M Agelidis; Deepak Shukla
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

10.  4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro.

Authors:  J M Woods; R C Bethell; J A Coates; N Healy; S A Hiscox; B A Pearson; D M Ryan; J Ticehurst; J Tilling; S M Walcott
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.